Inventor · disambiguated record
Jonathan Houze
Also filed as: HOUZE JONATHAN · HOUZE JONATHAN B
56 granted patents·8 pending applications·879 citations·filing 1999–2025
99Inventor score
Top patents by PatentIndex Score
64 records- 0198US9573936B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Feb 21, 2017·19 cites·56 claims
- 0297US10221162B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2018·Granted Mar 5, 2019·12 cites·22 claims
- 0397US9868721B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Jan 16, 2018·14 cites·60 claims
- 0497US9745286B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Aug 29, 2017·16 cites·52 claims
- 0597US9656998B2Intermediates for preparing triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted May 23, 2017·14 cites·16 claims
- 0696US6583157B2Quinolinyl and benzothiazolyl modulatorsTULARIK INC·Filed 2001·Granted Jun 24, 2003·64 cites·30 claims
- 0795US9845310B2Intermediates for preparing triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Dec 19, 2017·14 cites·16 claims
- 0895US9751864B2Methods for preparing triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted Sep 5, 2017·14 cites·28 claims
- 0995US9656997B2Triazole agonists of the APJ receptorAMGEN INC·Filed 2016·Granted May 23, 2017·16 cites·46 claims
- 1095US7144903B2CCR4 antagonistsAMGEN INC·Filed 2002·Granted Dec 5, 2006·90 cites·44 claims
- 1194US11718617B2Heterocyclic compounds as triggering receptor expressed on myeloid cells2 agonists and methods of useAMGEN INC·Filed 2022·Granted Aug 8, 2023·4 cites·30 claims
- 1294US11608344B2Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2021·Granted Mar 21, 2023·4 cites·30 claims
- 1394US7582803B2Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disordersAMGEN INC·Filed 2006·Granted Sep 1, 2009·17 cites·19 claims
- 1494US6869975B2Linked biaryl compoundsTULARIK INC·Filed 2002·Granted Mar 22, 2005·78 cites·28 claims
- 1594US6200995B1PPAR-γ modulatorsTULARIK INC·Filed 1999·Granted Mar 13, 2001·143 cites·58 claims
- 1693US11912711B2Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2022·Granted Feb 27, 2024·3 cites·30 claims
- 1793US11884675B2Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2022·Granted Jan 30, 2024·3 cites·30 claims
- 1893US6777446B2FXR modulatorsTULARIK INC·Filed 2001·Granted Aug 17, 2004·47 cites·12 claims
- 1992US7041691B1Compounds for the modulation of PPARγ activityAMGEN INC·Filed 2000·Granted May 9, 2006·38 cites·29 claims
- 2092US6770648B2Compounds for the modulation of PPARγ activityTULARIK INC·Filed 2002·Granted Aug 3, 2004·39 cites·58 claims
- 2190US10150760B2Compounds for use in preparing heterocyclic triazole agonists of the APJ receptorAMGEN INC·Filed 2018·Granted Dec 11, 2018·8 cites·29 claims
- 2290US6620827B2PPARγ modulatorsTULARIK INC·Filed 2000·Granted Sep 16, 2003·36 cites·33 claims
- 2389US9988369B2Heterocyclic triazole compounds as agonists of the APJ receptorAMGEN INC·Filed 2017·Granted Jun 5, 2018·8 cites·67 claims
- 2489US7816367B2Compounds, pharmaceutical compositions and methods for use in treating metabolic disordersAMGEN INC·Filed 2005·Granted Oct 19, 2010·15 cites·25 claims
- 2588US7968567B2Compounds for the modulation of PPARγ activityAMGEN INC·Filed 2009·Granted Jun 28, 2011·8 cites·4 claims
- 2687US7960408B2Quinolinyl and benzothiazolyl modulatorsAMGEN INC·Filed 2009·Granted Jun 14, 2011·4 cites·16 claims
- 2786US8030354B2Substituted biphenyl GPR40 modulatorsAMGEN INC·Filed 2008·Granted Oct 4, 2011·11 cites·96 claims
- 2885US7649110B2Compounds, pharmaceutical compositions and methods for use in treating metabolic disordersAMGEN INC·Filed 2005·Granted Jan 19, 2010·8 cites·37 claims
- 2983US8450522B2Conformationally constrained carboxylic acid derivatives useful for treating metabolic disordersBROWN SEAN P·Filed 2009·Granted May 28, 2013·9 cites·17 claims
- 3083US7687526B2Benzo-fused compounds for use in treating metabolic disordersAMGEN INC·Filed 2007·Granted Mar 30, 2010·5 cites·18 claims
- 3183US7439242B2PPARγ modulatorsAMGEN INC·Filed 2002·Granted Oct 21, 2008·14 cites·80 claims
- 3282US12428425B2Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2023·Granted Sep 30, 2025·0 cites·18 claims
- 3382US7626033B2Compounds for the modulation of PPARγ activityAMGEN INC·Filed 2004·Granted Dec 1, 2009·12 cites·46 claims
- 3481US12319691B2Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2023·Granted Jun 3, 2025·0 cites·20 claims
- 3581US11306107B2Compounds that inhibit MCL-1 proteinAMGEN INC·Filed 2017·Granted Apr 19, 2022·2 cites·11 claims
- 3681US7572934B2Substituted biphenyl GPR40 modulatorsAMGEN INC·Filed 2008·Granted Aug 11, 2009·5 cites·70 claims
- 3781US6214880B1Arylsulfonanilide ureasTULARIK INC·Filed 1999·Granted Apr 10, 2001·38 cites·26 claims
- 3880US11046680B1Heteroaryl-substituted triazoles as APJ receptor agonistsAMGEN INC·Filed 2017·Granted Jun 29, 2021·2 cites·33 claims
- 3978US7465804B2Compounds, pharmaceutical compositions and methods for their use in treating metabolic disordersAMGEN INC·Filed 2006·Granted Dec 16, 2008·3 cites·48 claims
- 4077US7645779B2Linked biaryl compoundsAMGEN INC·Filed 2004·Granted Jan 12, 2010·9 cites·24 claims
- 4177US6211167B1Arylsulfonanilide phosphatesTULARIK INC·Filed 2000·Granted Apr 3, 2001·8 cites·63 claims
- 4276US6583165B2Arylsulfonanilide ureasTULARIK INC·Filed 2001·Granted Jun 24, 2003·6 cites·33 claims
- 4374US10906890B2Triazole phenyl compounds as agonists of the APJ receptorAMGEN INC·Filed 2017·Granted Feb 2, 2021·1 cites·20 claims
- 4474US2025388574A1Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2025·Application pending·0 cites
- 4573US11020395B2Cycloalkyl substituted triazole compounds as agonists of the APJ receptorAMGEN INC·Filed 2017·Granted Jun 1, 2021·1 cites·26 claims
- 4673US10689367B2Triazole pyridyl compounds as agonists of the APJ receptorAMGEN INC·Filed 2017·Granted Jun 23, 2020·1 cites·30 claims
- 4773US8748462B2Spirocyclic GPR40 modulatorsBROWN SEAN P·Filed 2009·Granted Jun 10, 2014·2 cites·25 claims
- 4873US8003648B2Heterocyclic GPR40 modulatorsAMGEN INC·Filed 2009·Granted Aug 23, 2011·1 cites·10 claims
- 4971US12252489B2Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of useAMGEN INC·Filed 2021·Granted Mar 18, 2025·0 cites·23 claims
- 5070US10736883B2Triazole furan compounds as agonists of the APJ receptorAMGEN INC·Filed 2017·Granted Aug 11, 2020·1 cites·25 claims
Showing the top 50 of 64 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →